CSIMarket Company Name, Ticker, Industry, else..
 
Ispecimen inc   (NASDAQ: ISPC)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 
Price: $1.5400 $0.00 0.000%
Day's High: $1.5700000524520874 Week Perf: 0.00
Day's Low: $ 1.51 30 Day Perf: -30 %
Volume (M): 1,446,658 52 Wk High: $ 127.20
Volume (M$): $ 0 52 Wk Avg: $14.56
Open: $1.53 52 Wk Low: $1.40



 Market Capitalization (Millions $) 2
 Shares Outstanding (Millions) 1
 Employees 7
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -11
 Cash Flow (TTM) (Millions $) 2
 Capital Exp. (TTM) (Millions $) 2

Business Description


Ispecimen Inc. is a technology company that specializes in providing biospecimen supply and data services to the healthcare and life sciences industries. They have developed a unique platform that enables researchers and drug developers to access and obtain high-quality human biospecimens for their research and development activities. These specimens include blood, tissue, and other biological materials, which are crucial for advancing medical breakthroughs and improving patient care. Ispecimen Inc. also offers data services, where they aggregate and standardize clinical and research data to create valuable insights for their clients. By connecting healthcare providers, patients, and researchers, Ispecimen Inc. aims to accelerate the pace of medical research and ultimately contribute to better diagnostics, treatments, and cures for various diseases.


   Company Address: 8 Cabot Road Woburn 1801 MA
   Company Phone Number: 301-6700   Stock Exchange / Ticker: NASDAQ ISPC


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
DGX   -2.32%    
FCHS        3.75% 
NTRA        0.59% 
RDNT   -1.21%    
XGN        2.57% 
• View Complete Report
   



Management Announcement

iSpecimen Inc Charts a Promising Financial Course: Recent Public Offering and Strategic Developments Indicate Growth and Stability

Published Thu, Oct 31 2024 7:08 PM UTC

iSpecimen Inc. Charts a Promising Financial Course: Recent Public Offering and Strategic Developments Indicate Growth and StabilityiSpecimen Inc. Charts a Promising Financial Course: Recent Public Offering and Strategic Developments Indicate Growth and StabilityIn a significant development for investors and stakeholders alike, iSpecimen Inc. (Nasdaq: ISPC) has successfully c...
Financing Agreement

iSpecimen Inc Secures $1 Million Loan and Strengthens Leadership Amid Strategic Growth Initiatives

Published Thu, Sep 26 2024 11:30 AM UTC

iSpecimen Inc. Secures $1 Million Loan and Strengthens Leadership Amid Strategic Growth InitiativesIntroductionOn September 26, 2024, iSpecimen Inc. (Nasdaq: ISPC), a recognized player in the global marketplace for biospecimens, proudly announced the securing of a $1 million loan agreement. This financial boost accompanies the appointment of three new members to its Board of...
Shares

iSpecimen Announces 1-for-20 Reverse Stock Split

Published Wed, Sep 11 2024 8:30 PM UTC



iSpecimen Announces 1-for-20 Reverse Stock Split Amid Growth Ambitions: Prepares to Share Full Year 2023 Financial Results
WOBURN, Mass. Sept. 11, 2024nn iSpecimen Inc. (Nasdaq: ISPC), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced pivotal news today...
Announcement

iSpecimen Inc. Braces for Robust Growth as it Prepares to Share Full Year 2023 Financial Results

Published Tue, Mar 5 2024 9:30 PM UTC

iSpecimen Inc. (Nasdaq: ISPC), the pioneering online marketplace connecting scientists with healthcare specimen providers for research purposes, has announced that it will unveil its full year financial results for the period ending December 31, 2023, on March 13, 2024, as per the latest report. The company s headquarters in Lexington, Massachusetts, is buzzing with anticipa...
Partnership

iSpecimen, a leading supplier of human biospecimens, and TriMetis Life Sciences, a pioneer in digital AI histopathology services, have announced a strategic partnership aimed at revolutionizing tissue-based research By leveraging cutting-edge technology and expertise, these two companies aim to optimize quality control and assurance, ultimately enhancing the efficiency and accuracy of histopathology services

Published Tue, Jan 23 2024 12:30 PM UTC

iSpecimen, a leading supplier of human biospecimens, and TriMetis Life Sciences, a pioneer in digital AI histopathology services, have announced a strategic partnership aimed at revolutionizing tissue-based research. By leveraging cutting-edge technology and expertise, these two companies aim to optimize quality control and assurance, ultimately enhancing the efficiency and ...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 4.61
Price to Sales (Expected) -
Price to Book 1.24
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.43
Working Capital Ratio 0.44
Leverage Ratio (MRQ) 5.98
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -23.62 $
Revenues (TTM) 0.33 $
Cash Flow (TTM) 1.6 $
Cash 3.17 $
Book Value 1.25 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 66,615
Net Income per Employee (TTM) -1,631,418
Receivable Turnover Ratio (TTM) 5.77
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.06

Profitability Ratios Current
Gross Margin (MRQ) 45.18 %
Operating Margin (MRQ) -897.06 %
Net Margin (MRQ) -896.94 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Ispecimen Inc's Segments
Asia Pacific    31.58 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.